Association of costs with somatic symptom severity in patients with medically unexplained symptoms

Journal of Psychosomatic Research

Volumn 75, Issue 4, 2013, Pages 370-375

  Konnopka, Alexander ^a   Kaufmann, Claudia ^b   König, Hans Helmut ^a   Heider, Dirk ^a   Wild, Beate ^b   Szecsenyi, Joachim ^b   Herzog, Wolfgang ^b   Heinrich, Sven ^a   Schaefert, Rainer ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Direct cost; Indirect cost; Medically unexplained symptoms; Somatic symptom severity; Somatoform disorder

Indexed keywords

ABSENTEEISM; ADULT; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICALLY UNEXPLAINED SYMPTOM; OUTPATIENT; PHARMACEUTICS; PRIMARY MEDICAL CARE; PRODUCTIVITY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RETIREMENT; RETROSPECTIVE STUDY; SOMATIC SYMPTOM SEVERITY; SYMPTOM; SYMPTOM ASSESSMENT; WORK CAPACITY;

DIRECT COST; INDIRECT COST; MEDICALLY UNEXPLAINED SYMPTOMS; SOMATIC SYMPTOM SEVERITY; SOMATOFORM DISORDER;

ADULT; ANIMALS; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; EFFICIENCY; FEMALE; GERMANY; HEALTH CARE COSTS; HUMANS; LENGTH OF STAY; LINEAR MODELS; MALE; MICE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRIMARY HEALTH CARE; QUESTIONNAIRES; RETIREMENT; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SOMATOFORM DISORDERS; WORK;

EID: 84885384969     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2013.08.011     Document Type: Article

References (41)

1. Fink P, Sorensen L, Engberg M, Holm M, Munk-Jorgensen P Somatization in primary care. Prevalence, health care utilization, and general practitioner recognition. Psychosomatics 1999, 40:330-338.
2. de Waal MW, Arnold IA, Eekhof JA, van Hemert AM Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry 2004, 184:470-476.
3. Toft T, Fink P, Oernboel E, Christensen K, Frostholm L, Olesen F Mental disorders in primary care: prevalence and co-morbidity among disorders. results from the functional illness in primary care (FIP) study. Psychol Med 2005, 35:1175-1184.
4. Henningsen P, Zipfel S, Herzog W Management of functional somatic syndromes. Lancet 2007, 369:946-955.
5. Smith GR The course of somatization and its effects on utilization of health care resources. Psychosomatics 1994, 35:263-267.
6. Hiller W, Fichter MM High utilizers of medical care: a crucial subgroup among somatizing patients. J Psychosom Res 2004, 56:437-443.
7. Smith GR, Monson RA, Ray DC Patients with multiple unexplained symptoms. Their characteristics, functional health, and health care utilization. Arch Intern Med 1986, 146:69-72.
8. Barsky AJ, Orav EJ, Bates DW Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005, 62:903-910.
9. Labott SM, Preisman RC, Popovich J, Iannuzzi MC Health care utilization of somatizing patients in a pulmonary subspecialty clinic. Psychosomatics 1995, 36:122-128.
10. Barsky AJ, Ettner SL, Horsky J, Bates DW Resource utilization of patients with hypochondriacal health anxiety and somatization. Med Care 2001, 39:705-715.
11. Konnopka A., Schaefert R., Heinrich S., Kaufmann C., Luppa M., Herzog W., et al. Economics of medically unexplained symptoms: a systematic review of the literature 2012, 81:265-275.
12. Hiller W, Fichter MM, Rief W A controlled treatment study of somatoform disorders including analysis of healthcare utilization and cost-effectiveness. J Psychosom Res 2003, 54:369-380.
13. Schaefert R., Kaufmann C., Bölter R., Faber R., Wild B., Szecsenyi J., et al. Somatoform syndromes in primary care. Manual for interdisciplinary group therapy. Psychotherapeut 2011, 56:315-324.
14. Schaefert R., Kaufmann C., Wild B., Schellberg D., Boelter R., Faber R., et al. Specific Collaborative Group Intervention for Patients with Medically Unexplained Symptoms in General Practice (speciAL): a cluster randomized controlled trial. Psychother Psychosom 2013, 82(2):106-119. (accepted for publication).
15. Kroenke K, Spitzer RL, Williams JB, Lowe B The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry 2010, 32:345-359.
16. Fink P., Ewald H., Jensen J., Sorensen L., Engberg M., Holm M., et al. Screening for somatization and hypochondriasis in primary care and neurological in-patients: a seven-item scale for hypochondriasis and somatization. J Psychosom Res 1999, 46:261-273.
17. Christensen K, Fink P, Toft T, Frostholm L, Ornbol E, Olesen F A brief case-finding questionnaire for common mental disorders: the CMDQ. Fam Pract 2005, 22:448-457.
18. Conradt M, Cavanagh M, Franklin J, Rief W Dimensionality of the Whiteley Index: assessment of hypochondriasis in an Australian sample of primary care patients. J Psychosom Res 2006, 60:137-143.
19. Benedikt G., Schulmeister E., Sattel H., Schaefert R., Sauer N., Herzog W., et al. Somatic symptoms and illness worries in primary care - a study of 1751 general practice attenders. Z Psychiatr Psychol Psychother 2007, 55:21-29.
20. Schaefert R, Hausteiner-Wiehle C, Hauser W, Ronel J, Herrmann M, Henningsen P Non-specific, functional, and somatoform bodily complaints. Dtsch Arztebl Int 2012, 109:803-813.
21. Löwe B, Spitzer RL, Zipfel S, Herzog W PHQ-D Gesundheitsfragebogen für Patienten. Komplettversion und Kurzform. Autorisierte deutsche Version des. Prime MD Patient Health Questionnaire 2002.
22. Kroenke K, Spitzer RL, Williams JB The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002, 64:258-266.
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
24. Roick C, Kilian R, Matschinger H, Bernert S, Mory C, Angermeyer MC German adaptation of the client sociodemographic and service receipt inventory - an instrument for the cost of mental health care. Psychiatr Prax 2001, 28:S84-S90.
25. Reilly MC, Zbrozek AS, Dukes EM The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993, 4:353-365.
26. Krauth C, Hessel F, Hansmeier T, Wasem J, Seitz R, Schweikert B Empirical standard costs for health economic evaluation in Germany - a proposal by the working group methods in health economic evaluation. Gesundheitswesen 2005, 67:736-746.
27. Verband deutscher Rentenversicherungsträger VDR Statistik der Deutschen Rentenversicherung, Rehabilitation 2007 - Band 169 2008, Verband Deutscher Rentenversicherungsträger, Würzburg.
28. Verband der Angestelltenkrankenkassen e.V. VDAK. Vergütungslisten für ambulante Leistungen, Anlage zum Vertrag über die Erbringung ambulanter Leistungen. Verband Deutscher Angestelltenkrankenkassen E.V.: (Access May 11, 2009). http://www.Kvhb.De/Verordnungen/Heilmittel.Php.
29. Kassenärztliche Bundesvereinigung. Gebührenordnung für Ärzte. Download: (access: may/2009). https://www.aerztekammer-bw.de/20/goae/volltext.pdf.
30. Liste Rote 2007 Arzneimittelverzeichnis für Deutschland. Rote Liste Service GmbH 2009, ECV Editio Cantor Verlag, Frankfurt am Main.
31. Einkommensteuergesetzbuch (EStG) Version 2006, §9.4. Bundesgesetzblatt Teil 1 2006.
32. Statistisches Bundesamt Verdienste und Arbeitskosten 2006 2009, Statistisches Bundesamt, Wiesbaden.
33. Statistisches Bundesamt Arbeitskostenerhebungen - Arbeitskosten im Produzierenden Gewerbe und im Dienstleistungsbereich, Ergebnisse für Deutschland 2004 2007, Statistisches Bundesamt, Wiesbaden.
34. Statistisches Bundesamt Statistisches Jahrbuch 2008 für die Bundesrepublik Deutschland 2009, Statistisches Bundesamt, Wiesbaden.
35. Statistisches Bundesamt Verdienste und Arbeitskosten, Indizes der Arbeitnehmerverdienste 2007 2009, Statistisches Bundesamt, Wiesbaden.
36. Efron B, Tibshirani R Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy 1986, 54-77.
37. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Publishing. 5th ed.
38. Toft T, Rosendal M, Ornbol E, Olesen F, Frostholm L, Fink P Training general practitioners in the treatment of functional somatic symptoms: effects on patient health in a cluster-randomised controlled trial (the Functional Illness in Primary Care study). Psychother Psychosom 2010, 79:227-237.
39. Smith R.C., Lyles J.S., Gardiner J.C., Sirbu C., Hodges A., Collins C., et al. Primary care clinicians treat patients with medically unexplained symptoms: a randomized controlled trial. J Gen Intern Med 2006, 21:671-677.
40. Aiarzaguena JM, Grandes G, Gaminde I, Salazar A, Sanchez A, Arino J A randomized controlled clinical trial of a psychosocial and communication intervention carried out by GPs for patients with medically unexplained symptoms. Psychol Med 2007, 37:283-294.
41. Gask L, Dowrick C, Salmon P, Peters S, Morriss R Reattribution reconsidered: narrative review and reflections on an educational intervention for medically unexplained symptoms in primary care settings. J Psychosom Res 2011, 71:325-334.